These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16479431)

  • 1. Successful treatment of gastroparesis following total esophagectomy using botulinum toxin.
    Tcherniak A; Kashtan DH; Melzer E
    Endoscopy; 2006 Feb; 38(2):196. PubMed ID: 16479431
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin A for the treatment of delayed gastric emptying.
    Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
    Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond gastric emptying: a "toxic" lesson about gastroparesis.
    Pasricha PJ
    Am J Gastroenterol; 2008 Feb; 103(2):424-6. PubMed ID: 18289204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new combination therapy for diabetic gastroparesis].
    Hummel M; Fuechtenbusch M
    Z Gastroenterol; 2009 Dec; 47(12):1216-20. PubMed ID: 19960400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin as therapeutic agent in local hyperhydrosis.
    Jain S; Tamer SK; Hiran S
    J Assoc Physicians India; 2002 Feb; 50():273-4. PubMed ID: 12038664
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute reversible gastroparesis and megaduodenum after botulinum toxin injection for achalasia.
    Radaelli F; Paggi S; Terreni N; Toldi A; Terruzzi V
    Gastrointest Endosc; 2010 Jun; 71(7):1326-7. PubMed ID: 20304403
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin injections for achalasia symptoms.
    Horgan S; Pellegrini CA
    Am J Gastroenterol; 1999 Feb; 94(2):300-1. PubMed ID: 10022619
    [No Abstract]   [Full Text] [Related]  

  • 8. The medical management of masseteric hypertrophy with botulinum toxin.
    Finn S; Ryan P; Sleeman D
    J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
    Gil RA; Hwynn N; Fabian T; Joseph S; Fernandez HH
    Parkinsonism Relat Disord; 2011 May; 17(4):285-7. PubMed ID: 21296606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meige syndrome: a rare form of cranial dystonia that was treated successfully with botulinum toxin.
    Sabesan T
    Br J Oral Maxillofac Surg; 2008 Oct; 46(7):588-90. PubMed ID: 18346825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-surgical management of parotid gland and duct injuries: interest of botulinum toxin].
    Arnaud S; Batifol D; Goudot P; Yachouh J
    Ann Chir Plast Esthet; 2008 Feb; 53(1):36-40. PubMed ID: 17382446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.
    Ezzeddine D; Jit R; Katz N; Gopalswamy N; Bhutani MS
    Gastrointest Endosc; 2002 Jun; 55(7):920-3. PubMed ID: 12024156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of botulinum toxin a injection compared with topical nitroglycerin ointment for the treatment of chronic anal fissure: a prospective randomized study.
    Fruehauf H; Fried M; Wegmueller B; Bauerfeind P; Thumshirn M
    Am J Gastroenterol; 2006 Sep; 101(9):2107-12. PubMed ID: 16848808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
    Song PC; Schwartz J; Blitzer A
    Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment on: neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
    Wyndaele JJ
    Eur Urol; 2008 May; 53(5):1019-20. PubMed ID: 17950988
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: regression of relapsing dyshidrotic eczema after treatment of concomitant hyperhidrosis with botulinum toxin-A.
    Kontochristopoulos G; Gregoriou S; Agiasofitou E; Nikolakis G; Rigopoulos D; Katsambas A
    Dermatol Surg; 2007 Oct; 33(10):1289-90. PubMed ID: 17903169
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
    Casserly P; Timon C
    J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cutaneous uses for botulinum toxin type A.
    Bansal C; Omlin KJ; Hayes CM; Rohrer TE
    J Cosmet Dermatol; 2006 Sep; 5(3):268-72. PubMed ID: 17177750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.